HR 7552 United States House · 119th Congress

CBW Fentanyl Act

This bill expands existing U.S. sanctions authority to target foreign countries whose chemical or biological programs cause harm to other nations. It requires the President to investigate and sanction foreign officials or entities involved in such harmful activities, with specific focus on programs producing benzylfentanyl, 4-anilinopiperidine, or norfentanyl precursors. The law establishes a three-stage sanctions process: initial restrictions on scientific cooperation and certain exports, intermediate measures that may cut off foreign assistance and additional export controls, and final sanctions that prohibit financial transactions involving the affected country. Sanctions can be lifted if the foreign government addresses the harm, provides information, and takes steps to prevent future incidents, with a five-year limit on presidential waiver authority.
Bill status in committee 1 of 4 stages cleared
Introduction
Feb 2026
Committee Review
Floor Vote
President
Introduced Feb 12, 2026 Last action Feb 12, 2026
Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
2
Key actions
0
Committee
1
Feb 12, 2026
Committee
Referred to the Committee on Foreign Affairs, and in addition to the Committees on Financial Services, and Oversight and Government Reform, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
lower
Feb 12, 2026
Introduced
Introduced in House
lower
1 primary · 2 co-sponsors

Sponsors